4Simon LS,Weaver AL,Graharm DY,et al.Ariti-inflamma-tory and and upper gastrointestinal effects of celecoxin in rheumatoid arthritis:a randomized Controlled trial[J].JAMA,1999,282:191～1928.
5Saag k,Fisher C,mckay J,et al.mk-0996,a specific cox-2 inhibitor,has clinical effcacy comparable to diclofenac in the treatment of knee and hip osteoarthritis in a 26 week controlld clinical trial[J].Arthritis Rheum,1998,41(9):583.
6Dougados M,Behier Jm,Jdchine I,et al.Eficacy of celecoxib,acyclooxygenase 2-specirfic inhibitor,in the treatment of ankylosing spondylitis:a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antinfla mmatory drug[J].Aithritis-Rheum,2001,44(1):180～185.
7Dougados M,Gueguen A,Nakache JP,et al.Ankylosing spondylitis:what is the optimum daration of a clinical study?Aone year versus a 6 weeks non-steroidol anti-inflammatory drug trial[J].Rheumatology-Oxford,1999,38(3):235～244.
8maugars Y,mathis C,Berthelot M,et al.Assessment of the efficacy of sacroiliac corticosteroid injections in spondy larthropathies:a double-blind study[J].Br-J-Rheumatol,1996,35(8):767～770.
9Toussirot E,wendlling D.Current guidelines for the drug treatment of ankylosing spondylitis[J].Drugs,1998,56(2):225～230.
10Dekker-Saeys BJ,Dijkmans BA,Tytgat GN.Treatment of spondyloaithropathy witl 5-aminosalicylic acid(mesalazine)an open trial[J].J-Rheumatol,2000,27(3):723～726.
